Keywords: Cephalon, Mesoblast, Regenerative medicne, Stem cells, Parkinsons's, Alzheimer's, Cardiovascular, CNS

Cephalon in up to $1.8 billion alliance with Mesoblast for regenerative medicine, plus stake in the firm

Article | 09 December 2010

Print This

Australia’s Mesoblast (ASX: MSB) saw its shares rocket as much as to hit a higher of A$4.45, before ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in